Protara Therapeutics, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Protara Therapeutics, Inc. (TARA) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $62.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2021-11-04
- Protara Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2021-09-30 was $62.00K.
- Protara Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2021-06-30 was $63.00K.
- Protara Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2021-03-31 was -$164.00K.
- Protara Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2019-12-31 was $1.00K.
- Protara Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2019 was -$2.00K, a 110.53% decline from fiscal 2018.
- Protara Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2018 was $19.00K.
- Protara Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2017 was -$14.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2021-09-30 | $62.00K 10-Q · filed 2021-11-04 | $125.00K derived: sum of 2 quarters · filed 2021-11-04 | -$39.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $63.00K 10-Q · filed 2021-08-05 | -$101.00K 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | -$164.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $1.00K derived: 10-K 12 month − 3 quarters · filed 2020-03-20 | -$1.00K derived: sum of 2 quarters · filed 2020-03-20 | $0.00 derived: sum of 3 quarters · filed 2020-03-20 | -$2.00K 10-K · filed 2020-03-20 |
| 2019-09-30 | -$2.00K 10-Q · filed 2019-10-31 | -$1.00K derived: sum of 2 quarters · filed 2019-10-31 | -$3.00K derived: sum of 3 quarters · filed 2019-10-31 | |
| 2019-06-30 | $1.00K 10-Q · filed 2019-10-31 | -$1.00K derived: sum of 2 quarters · filed 2019-10-31 | ||
| 2019-03-31 | -$2.00K 10-Q · filed 2019-10-31 | |||
| 2018-12-31 | $19.00K 10-K · filed 2020-03-20 | |||
| 2018-09-30 | $3.00K 10-Q · filed 2019-10-31 | $8.00K derived: sum of 2 quarters · filed 2019-10-31 | $18.00K derived: sum of 3 quarters · filed 2019-10-31 | |
| 2018-06-30 | $5.00K 10-Q · filed 2019-10-31 | $15.00K derived: sum of 2 quarters · filed 2019-10-31 | ||
| 2018-03-31 | $10.00K 10-Q · filed 2019-10-31 | |||
| 2017-12-31 | -$14.00K 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |